Uw webbrowser is verouderd

Met een bijgewerkte browser heeft u een betere ervaring met de website van Medtronic. Werk mijn browser nu bij.

×

Skip to main content

CLINICAL EVIDENCE — REAL WORLD RESULTS TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI)

   Indications, Safety, and Warnings

EXCELLENT RESULTS DEMONSTRATED IN REAL-WORLD SETTINGS

Data indicates the Medtronic TAVI platform clinical performance provides reproducible results and performs well over time.

FORWARD STUDY1

This multicenter, prospective, single-arm, observational post-market study evaluated the safety and performance of the Evolut R system in a routine hospital setting.

  • Study Status/Duration: 12-month outcomes reported/3-year follow-up
  • Sample Size: N = 1040
  • Devices: Evolut R TAV

1 year hemodynamic data
Valve Performance

SEE DATA

30-day procedural outcomes
All Cause Rates

 

ADVANCE Study2

ADVANCE is a multicenter, prospective, single-arm, observational study to evaluate safety and performance of the CoreValve™ system in a routine clinical setting.

Study Status/Duration: 5-year outcomes reported/5-year follow-up
Sample Size: N = 1,015
Devices: CoreValve, TAV

SEE STUDY DATA

Graph showing effective orifice area and mean gradient over 5 years.
View Larger

For a summary of all TAVI clinical studies, see Clinical Evidence Compendium

STAY INFORMED

Receive email updates about Medtronic TAVI.

SIGN UP

MEDTRONIC ACADEMY

View more clinical data and access procedural resources.

LOG IN OR REGISTER
1

Grube, as presented at EuroPCR 2018

2

Gerckens U, Tamburino C, Bleiziffer S, et al. Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study. Eur Heart J. September 21, 2017;38(36):2729-2738.